We use cookies in order to analyze traffic of this website. Your further use of this website will be considered consent. For more information visit our Cookie Policy.

About us

Science

Pipeline

Media

Investors

Join us

Contact us

At AC Immune, we are passionate about making a difference in the lives of people affected by Alzheimer’s and other neurodegenerative diseases. Our goal is to become the global leader in precision medicine of neurodegenerative diseases that are one of the biggest challenges facing society today and future generations.

Latest news

September 4, 2019

AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent

August 14, 2019

AC Immune Reports Q2 2019 Financial Results, Business and Clinical Update

August 12, 2019

AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases

News features

September 12, 2019

To mark World Alzheimer's Month, AC Immune's CEO Andrea Pfeifer shared her thoughts in the latest edition of Pharmaceutical Market Europe (PME)

August 20, 2019

CEO Andrea Pfeifer Prof. Andrea Pfeifer speaks with Laura Elizabeth Lansdowne, Science Writer for Technology Networks

Company information

Discover more about us, who we are, and how we innovate to improve neurodegenerative disease understanding and develop breakthrough therapies.

Product pipeline

One of the world’s largest Alzheimer’s product pipelines with complementary diagnostic agents driven by proprietary technology platforms.

Stock information

Up to date company stock information and analytics directly from Nasdaq